CLSDQ · Clearside Biomedical, Inc. · Earnings Call Transcripts & Audio
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. Based on our current plans and forecasted expenses and our cash and cash equivalents, we do not believe we will be able to fund our operations for the next 12 months from the date of this filing.”View the 10-Q filed Nov 14, 2025
Market Cap
$1.30M
Shares
5.23M
Clearside Biomedical, Inc. Earnings Call Transcripts
Quarterly earnings calls for Clearside Biomedical, Inc. (CLSDQ), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼99.2%
$34,000
−$7.35M
'21 Q1
21-05-17
▲120.3%
$780,000
−$6.09M
'21 Q2
21-08-10
▼10.4%
$3.07M
−$4.89M
'21 Q3
21-11-10
▲233418.2%
$25.69M
$18.71M
'21 Q4
22-03-10
▲920.6%
$347,000
−$7.64M
'22 Q1
22-05-11
▼50.8%
$384,000
−$7.81M
'22 Q2
22-08-09
▼91.3%
$266,000
−$7.83M
'22 Q3
22-11-09
▼98.7%
$330,000
−$9.66M
'22 Q4
23-03-09
▼98.8%
$4,000
−$9.28M
'23 Q1
23-05-11
▲165.1%
$1.02M
−$9.11M
'23 Q2
23-08-14
▲222.9%
$859,000
−$9.27M
'23 Q3
23-11-13
▲1822.7%
$6.34M
−$4.83M
'23 Q4
24-03-12
▲5650%
$230,000
−$11.76M
'24 Q1
24-05-09
▼91.2%
$90,000
−$7.59M
'24 Q2
24-08-12
▲20.8%
$1.04M
−$7.69M
'24 Q3
24-11-12
LATEST
▼95.2%
$306,000
−$7.31M
'24 Q4
25-03-27
Earnings call
FY24 · Q4
2025-03-27
Clearside Biomedical, Inc. (CLSDQ) Q4 2024 Earnings Call
Revenue
$306,000*
▼ 95.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Clearside Biomedical, Inc. (CLSDQ) Q3 2024 Earnings Call
Revenue
$1.04M
▲ 20.8% YoY Diluted EPS
$-1.54
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Clearside Biomedical, Inc. (CLSDQ) Q2 2024 Earnings Call
Revenue
$90,000
▼ 91.2% YoY Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Clearside Biomedical, Inc. (CLSDQ) Q1 2024 Earnings Call
Revenue
$230,000
▲ 5650% YoY Diluted EPS
$-0.17
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
Clearside Biomedical, Inc. (CLSDQ) Q4 2023 Earnings Call
Revenue
$6.34M*
▲ 1822.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Clearside Biomedical, Inc. (CLSDQ) Q3 2023 Earnings Call
Revenue
$859,000
▲ 222.9% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Clearside Biomedical, Inc. (CLSDQ) Q2 2023 Earnings Call
Revenue
$1.02M
▲ 165.1% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Clearside Biomedical, Inc. (CLSDQ) Q1 2023 Earnings Call
Revenue
$4,000
▼ 98.8% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-09
Clearside Biomedical, Inc. (CLSDQ) Q4 2022 Earnings Call
Revenue
$330,000*
▼ 98.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Clearside Biomedical, Inc. (CLSDQ) Q3 2022 Earnings Call
Revenue
$266,000
▼ 91.3% YoY Diluted EPS
$-0.13
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Clearside Biomedical, Inc. (CLSDQ) Q2 2022 Earnings Call
Revenue
$384,000
▼ 50.8% YoY Diluted EPS
$-0.13
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-11
Clearside Biomedical, Inc. (CLSDQ) Q1 2022 Earnings Call
Revenue
$347,000
▲ 920.6% YoY Diluted EPS
$-0.13
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Clearside Biomedical, Inc. (CLSDQ) Q4 2021 Earnings Call
Revenue
$25.69M*
▲ 233418.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Clearside Biomedical, Inc. (CLSDQ) Q3 2021 Earnings Call
Revenue
$3.07M
▼ 10.4% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Clearside Biomedical, Inc. (CLSDQ) Q2 2021 Earnings Call
Revenue
$780,000
▲ 120.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-17
Clearside Biomedical, Inc. (CLSDQ) Q1 2021 Earnings Call
Revenue
$34,000
▼ 99.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-10
Clearside Biomedical, Inc. (CLSDQ) Q4 2020 Earnings Call
Revenue
$11,000*
▼ 99.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Clearside Biomedical, Inc. (CLSDQ) Q3 2020 Earnings Call
Revenue
$3.43M
▲ 2334% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Clearside Biomedical, Inc. (CLSDQ) Q2 2020 Earnings Call
Revenue
$354,000
▲ 686.7% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-28
Clearside Biomedical, Inc. (CLSDQ) Q1 2020 Earnings Call
Revenue
$4.10M
▲ 9004.4% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-11
Clearside Biomedical, Inc. (CLSDQ) Q4 2019 Earnings Call
Revenue
$1.94M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Showing 1–21 of 21 earnings calls